Byfavo 50 mg powder for concentrate for solution for injection / infusion

Licence status
Authorised: 31/03/2023
Active substances
Remimazolam besilate
Dosage Form
Powder for concentrate for solution for injection/infusion
Licence number
EU/1/20/1505/002
Licence holder
Paion Pharma GmbH

Product documents

Licence information

ATC code
N05CD14 remimazolam
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
31/03/2023